Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes
Autor: | Hiroko Miyamoto, Kosuke Okuya, Akina Mori-Kajihara, Ayato Takada, Reiko Yoshida, Masahiro Kajihara, Rashid Manzoor, Takeshi Saito, Tadaki Suzuki, Masahiro Sato, Yurie Kida, Osamu Ichii, Hideaki Higashi, Michihito Sasaki, Shinji Saito, Tatsunari Kondoh |
---|---|
Rok vydání: | 2020 |
Předmět: |
Cross Protection
Hemagglutinin Glycoproteins Influenza Virus budding Antibodies Viral medicine.disease_cause Influenza A Virus H2N2 Subtype Madin Darby Canine Kidney Cells law.invention Mice Influenza A Virus H1N1 Subtype law antibody Influenza A virus Virus Release Mice Inbred BALB C 0303 health sciences Antibodies Monoclonal broadly cross-reactive Recombinant DNA Female Antibody IgA medicine.drug_class Immunology cross-protective immunity Hemagglutinin (influenza) Cross Reactions Biology Monoclonal antibody Microbiology Virus 03 medical and health sciences Dogs Orthomyxoviridae Infections Neutralization Tests Immunity Virology Influenza Human Vaccines and Antiviral Agents medicine Animals Humans hemagglutinin Immunity Mucosal 030304 developmental biology Influenza A Virus H5N1 Subtype 030306 microbiology Antibodies Neutralizing nonneutralizing Influenza A virus subtype H5N1 Immunoglobulin A HEK293 Cells Immunoglobulin G Insect Science biology.protein |
Zdroj: | J Virol |
ISSN: | 1098-5514 0022-538X |
Popis: | IgA antibodies on mucosal surfaces are known to play an important role in protection from influenza A virus (IAV) infection and are believed to be more potent than IgG for cross-protective immunity against IAVs of multiple hemagglutinin (HA) subtypes. However, in general, neutralizing antibodies specific to HA are principally HA subtype specific. Here, we focus on nonneutralizing but broadly cross-reactive HA-specific IgA antibodies. Recombinant IgG, monomeric IgA (mIgA), and polymeric secretory IgA (pSIgA) antibodies were generated based on the sequence of a mouse anti-HA monoclonal antibody (MAb) 5A5 that had no neutralizing activity but showed broad binding capacity to multiple HA subtypes. While confirming that there was no neutralizing activity of the recombinant MAbs against IAV strains A/Puerto Rico/8/1934 (H1N1), A/Adachi/2/1957 (H2N2), A/Hong Kong/483/1997 (H5N1), A/shearwater/South Australia/1/1972 (H6N5), A/duck/England/1/1956 (H11N6), and A/duck/Alberta/60/1976 (H12N5), we found that pSIgA, but not mIgA and IgG, significantly reduced budding and release of most of the viruses from infected cells. Electron microscopy demonstrated that pSIgA deposited newly produced virus particles on the surfaces of infected cells, most likely due to tethering of virus particles. Furthermore, we found that pSIgA showed significantly higher activity to reduce plaque sizes of the viruses than IgG and mIgA. These results suggest that nonneutralizing pSIgA reactive to multiple HA subtypes may play a role in intersubtype cross-protective immunity against IAVs. IMPORTANCE Mucosal immunity represented by pSIgA plays important roles in protection from IAV infection. Furthermore, IAV HA-specific pSIgA antibodies are thought to contribute to cross-protective immunity against multiple IAV subtypes. However, the mechanisms by which pSIgA exerts such versatile antiviral activity are not fully understood. In this study, we generated broadly cross-reactive recombinant IgG and pSIgA having the same antigen-recognition site and compared their antiviral activities in vitro. These recombinant antibodies did not show "classical" neutralizing activity, whereas pSIgA, but not IgG, significantly inhibited the production of progeny virus particles from infected cells. Plaque formation was also significantly reduced by pSIgA, but not IgG. These effects were seen in infection with lAVs of several different HA subtypes. Based on our findings, we propose an antibody-mediated host defense mechanism by which mucosal immunity may contribute to broad cross-protection from lAVs of multiple HA subtypes, including viruses with pandemic potential. |
Databáze: | OpenAIRE |
Externí odkaz: |